Tuesday, June 7, 2022
- 7:00pm-8:00pm
-
Preliminary Data of the Safety and Immunogenicity Protocol of Vaccination for SARS-CoV 2 in Solid Organ Transplant Patients in Argentina
All Infections (Excluding Kidney & Viral Hepatitis) IV • Hynes Halls C & D
- 7:00pm-8:00pm
-
Prevention of the Progression in Chronic Calcineurin Inhibitors Nephrotoxicity via Steroids Anti-Inflammatory Effects
Poster Chat: Kidney 1 • Hynes Hall C
- 7:00pm-8:00pm
-
Process Evaluation of the Ascent Study: A Hybrid Type 1 Effectiveness-Implementation Trial of a Multi-Level Intervention to Improve Dialysis Provider Knowledge of Kidney Allocation Policy Changes and Increase Kidney Transplant Waitlisting
Health Equity and Access • Hynes Halls C & D
- 7:00pm-8:00pm
-
Progression from Kidney Transplant Referral to Initiating the Pre-Transplant Evaluation: What Causes the Break Down?
Health Equity and Access • Hynes Halls C & D
- 7:00pm-8:00pm
-
Prospective Evaluation of Donor-Derived Cell-Free DNA (dd-cfDNA) in Monitoring Response to Anti-Rejection Treatment in Kidney Transplant Recipients with Indication Biopsy
Biomarkers: Clinical Outcomes • Hynes Halls C & D
- 7:00pm-8:00pm
-
Pure Laparoscopic Donor Right Hepatectomy (PLDRH) – Can It be a Standardized, Reproducible and Cost Effective Procedure?
Liver: Living Donor Liver Transplant and Partial Grafts • Hynes Halls C & D
- 7:00pm-8:00pm
-
Pure Laparoscopic versus Open Right Hepatectomy in Living Liver Donors (Graft Weight Discrepancy)
Liver: Living Donor Liver Transplant and Partial Grafts • Hynes Halls C & D
- 7:00pm-8:00pm
-
Racial Differences in HLA Mismatch Potential Among Kidney Registrations
Health Equity and Access • Hynes Halls C & D
- 7:00pm-8:00pm
-
Racial Differences in the Predictability of Donor-Derived Cell-Free DNA Among Renal Transplant Recipients
Kidney: Acute Cellular Rejection • Hynes Halls C & D
- 7:00pm-8:00pm
-
Randomized, Phase 4 Study Evaluating the Pharmacokinetics and Tolerability of the New Tacrolimus Tablet Formulation (Tacrobell Tab) in Kidney Transplant Recipients
Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D
- «Previous Page
- 1
- …
- 42
- 43
- 44
- 45
- 46
- …
- 52
- Next Page»